OpenVSafe by OpenVAERS
Search V-safe

9AG-39305-79090

4 vaccinations 12 coded responses 28 check-ins 12 free-text entries 1 call case
Sex
Female
Age at first dose
51-55
ZIP prefix
301 / GA
Registered
2021-05-07
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-08
    Dose 1 — Moderna
  2. 2021-05-06
    Dose 2 — Moderna
  3. 2021-05-07
    Registered in v-safe
  4. 2021-05-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Adverse reaction, Heart rate increased — Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Had adverse reaction of elevated heart rate of 117.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-05-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Breast tenderness, Lymph node pain, Lymphadenopathy — Feeling: Fair · Fatigue or tiredness
    Free text: Swelling and pain of lymph node in left armpit & breast tenderness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-05-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: Swollen & tender lymph node under left armpit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-05-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Breast tenderness, Lymph node pain, Lymphadenopathy — Feeling: Good · Fatigue or tiredness
    Free text: Swollen & tender lymph node in left armpit; tenderness left breast
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-05-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-05-13
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-05-20
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-05-27
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-06-03
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-06-10
    Survey response — day 35, dose 2
    MedDRA: Fatigue — Feeling: Fair · Be unable to work
    Free text: Fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-06-17
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-08-05
    Survey response — 3 months, dose 2
    MedDRA: Dacryostenosis acquired, Migraine, Paranasal sinus hypersecretion, Vertigo — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Vertigo, migraine headaches, blocked tear duct and sinus discharge
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  16. 2021-08-05
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  17. 2021-11-05
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-11-23
  19. 2021-12-02
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  20. 2021-12-11
    Dose 3 — Pfizer-BioNTech
  21. 2021-12-27
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  22. 2022-01-01
    Survey response — day 21, dose 3
    MedDRA: Fatigue, Nasal congestion — Feeling: Fair
    Free text: Fatigue, stuffy nose
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-01-08
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  24. 2022-01-15
    Survey response — day 35, dose 3
    MedDRA: Headache, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair
    Free text: Congestion, sore throat, headache
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-01-23
    Survey response — day 42, dose 3
    MedDRA: Fatigue, Nasal congestion, Oropharyngeal pain — Feeling: Good
    Free text: Sore throat, fatigue, nasal congestion
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-03-12
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  27. 2022-06-13
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  28. 2022-09-22
    Dose 4 — Pfizer-BioNTech
  29. 2022-10-02
    Survey response — day 7, dose 4
    MedDRA: Adverse reaction — Feeling: Good
    Free text: Had extreme for first week after receiving the dose.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-10-08
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  31. 2022-10-13
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  32. 2022-10-20
    Survey response — day 28, dose 4
    MedDRA: Diarrhoea, Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Diarrhea, fatigue
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-10-27
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  34. 2022-11-04
    Survey response — day 42, dose 4
    MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school
    Free text: Common cold
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-12-24
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  36. 2023-03-23
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-08Moderna
22021-05-06Moderna
32021-12-11Pfizer-BioNTech No
42022-09-22Pfizer-BioNTech No

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 8 — days 1–6 daily, dose 2

2021-05-08

Systemic reaction (other): Had adverse reaction of elevated heart rate of 117.

2021-05-09

Systemic reaction (other): Swelling and pain of lymph node in left armpit & breast tenderness

2021-05-10

Systemic reaction (other): Swollen & tender lymph node under left armpit

2021-05-11

Systemic reaction (other): Swollen & tender lymph node in left armpit; tenderness left breast

Release 9 — day 35, dose 2

2021-06-10

Symptoms: Fatigue

Release 9 — 3 months, dose 2

2021-08-05

Symptoms: Vertigo, migraine headaches, blocked tear duct and sinus discharge

Release 10 — day 21, dose 3

2022-01-01

Symptoms: Fatigue, stuffy nose

Release 10 — day 35, dose 3

2022-01-15

Symptoms: Congestion, sore throat, headache

Release 11 — day 42, dose 3

2022-01-23

Symptoms: Sore throat, fatigue, nasal congestion

Release 12 — day 7, dose 4

2022-10-02

Systemic reaction (other): Had extreme for first week after receiving the dose.

Release 12 — day 28, dose 4

2022-10-20

Symptoms: Diarrhea, fatigue

Release 12 — day 42, dose 4

2022-11-04

Symptoms: Common cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDacryolith ○ · ○
SDDacryostenosis acquired ✓ · ✓
SDDiarrhoea · · ✓
SDFatigue ✓ ✓ ✓
SDHeadache · · ✓
SDMigraine ✓ · ✓
SDNasal congestion · · ✓
SDNasopharyngitis · · ✓
SDOropharyngeal pain · · ✓
SDParanasal sinus hypersecretion ✓ · ✓
SDRespiratory tract congestion · · ✓
SDVertigo ✓ · ✓
SROAdverse reaction ✓ ✓ ✓
SROBreast tenderness ✓ ✓ ✓
SROHeart rate increased ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release